This study was conducted to obtain acute information of the oral dose toxicity of lyophilized water extract of Pinelliae Rhizoma, a dried tuber of Pinellia temata (PR) in male and female mice. In order to calculated 50% lethal dose (LDso) and approximate lethal dose (ALD), test material was once orally administered to male and female ICR mice at dose levels of 2000, 1000, 500, 250, 125 and o (vehicle control) ml/kg (body weight). The mortality and changes in body weight, clinical signs, gross observation, organ weight and histopathology of principle organs were monitored 14 days after treatment with PR extract. We could not find any mortalities, clinical signs, changes in the body and organ weights, gross and histopathological findings except for dose-dependent increases in the hepatic fatty change frequencies detected in PR extract 2000 and 1000mg/kg treated in both male and female mice. The results obtained in this study suggest that LDso and approximate LD in mice after single oral dose of PR extracts were considered over 2000 mg/kg in both and female male mice, but more than 1000mg/kg of PR extracts treatment could induce slight hepatotoxicity the fatty changes in mice.
INTRODUCTION
A traditional Korean herbal medicine, Pinelliae Rhizoma (PR) is a dried tuber of Pinellia temata (Thunberg) Breitenbach (Family: Araceae), and has been used as sedative and antiemesis agents for pregnant (Ho and Liu, 1975; Maki et a/., 1987; Lee et aI., 1993; Kurata et aI., 1998) . Until now, various pharmacological effects of PR have been revealed; anti-cancer effect (Li et a/., 2007) , anti-obesity effect (Kim et aI., 2006) , emetic effect (Zhao et a/., 2005) , anti-emetic effect (Kurata et a/., 1998) and neuroprotective effect (Shi et a/., 1994) . In addition, the therapeutic effects on hepatitis B infections (Chen et a/., 2005) , neuroprotective effect (Koo et a/., 2005; Chung et a/., 2006) , anti-stress effect (Katagiri et a/., 2004) and gastric profusion effect (Chen et a/., 2002) of mixed herbal formula containing PR extracts also have been researched.
As increase of the concern in the functional food and well being in life, the demands and consumption of functional food originated from natural sources are increased (Lee et a/., 2003) . However, the toxicological aspects about these natural origin-functional foods has been neglected because of the reasons that they has been used as various purpose for long times. Therefore, it is considered that more detail and systemic toxicological studies should be tested for control the abuse and potential toxicities even if they have been used as traditional folk medicine. Although it has been regarded that PR is a representative toxic irritable herbs in Korean medicine (Park and Seo, 2000) , the scientific toxicological studies about PR extracts have not conducted except for 4 weeks repeated oral dose toxicity test in rats (Lee et a/., 2003) , cytotoxicity (Lee et a/., 1993) and some poster presentational gentoxicity (Yang et a/., 1990) . There are no repots dealing the toxicological aspects of PR water extracts in mouse, even if the basic single dose toxicities.
The objective of the present study, therefore, was to obtain the primary safety information about PR extracts, lyophilized water extract of Pinellia temata and further clarifies their safety for clinical use. In order to observe the 50% lethal dose (LD5o), approximate lethal dosage (ALD), test articles were once orally administered to female and male ICR mice at dose levels of 2000, 1000, 500 and 0 (control) mg/kg (body weight) according to the recommendation of KFDA Guidelines 2005) . The mortality and changes on body weight, clinical signs and gross observation were monitored during 14 days after oral administration of PR extracts according to Korea Food and Drug Administration (KFDA) Guidelines (2005 Guidelines ( -60, 2005 with organ weights and histopathology of 12 types of principle organs.
MATERIALS AND METHODS
Experimental animals. Each of twenty female and male ICR mice (6-wk old upon receipt, SLC, Japan) was used after acclimatization for 7 days. Five animals were allocated per a polycarbonate cage in a temperature (20-25°C) and humidity (40-45%) controlled room. Light : dark cycle was 12 h : 12 h and feed (Samyang, Korea) and water were supplied free to access. All animals were overnight fasted (about 18 h) before dosing and terminal necropsy. Animals were marked by picric acid.
Preparation of PR extracts. Aqueous PR extracts (absorption rate 29.36%) were prepared by routine methods using rotary vacuum evaporator (BUCHI Rotavapor R-144, Switzerland) and programmable freeze dryer (1lShin Lab., Korea) from PR, which were purchased from local voucher (Cho-Heung Pharmaceutical Ind. Co. (Daegu, Korea) after confirm the morphology under microscopy. Powders of PR extracts were light brown powder. PR extracts were stored in a refrigerator at -20°C to protect from light and degeneration. The appearance of PR extracts in vehicle was clear light brown solution in distilled water and it is well soluble upto 200 mg/ml concentration levels. The test article was single orally administered at a dosage volume of 20 ml/kg using distilled water as vehicle.
Grouping and dosing. The animals were distributed into 8 groups 5 mice per group upon receipt. PR extracts have been used as folk medicine and ingredients of medicinal food for long times and no revealed toxicological data was available, the highest dosage level was selected as 2000 mg/kg according to the recommended by KFDA (2005 KFDA ( -60, 2005 and Organization for Economic Co-Operation and Development (OECD) (2001) guidelines, the limited dosages, and 1000 and 500 mg/kg was selected using common ratio 2. In addition, a vehicle control group was added. Animal was once orally dosed using a sonde attached to a syringe of 1 ml after overnight fasting (about 18hr, water was not restricted). Feed and water were restricted further for about 3 h. Observation of clinical signs. All abnormal clinical signs were recorded before and after dosing at least twice a day based on the functional observational battery test (Irwin, 1968; Dourish, 1987) .
Body weight changes. Body weights were measured at the day of dosing (Day 0) immediately before treatment, 1,2,7, 13 and 14 days after dosing. In addition, to reduce the individual body weight differences of animals at initial dosing, body weigh gains during Day O-Day 7, Day 7-Day 13 and Day O-Day 14 were also calculated based on measured body weight at each day.
Necropsy. All unscheduled died animals were grossly observed immediately after finding them and all survived animals were subjected to terminal necropsy. Animals were asphyxiated by carbon dioxide and gross necropsy was performed in all animals at Day 14 after overnight fasting (about 18 h, water was not restricted).
Specific organs grossly observed: lung, heart, kidney, spleen, testis, liver, pancreas, epididymis, popliteal lymph node, ovary, brain, and uterus.
Organ weight measurement. The absolute organ weight was measured and then relative organ weight (% of body weight) was calculated for the following organs of all experimental animals when they were sacrificed.
Measured organs: lung, heart, kidney (left), spleen, testis (left), liver, pancreas (splenic lobes), epididymis (left), popliteal lymph node (left), ovary (left), brain, and uterus.
Histopathology. Principle organs listed below were sampled at terminal necropsy, and fixed in 10% NBF (neutral buffered formalin). After 18 h of fixation, paraffin embedding was conducted and 3-4 )lm sections were Values are expressed as mean ± S.D., 9 (n = 5); aDay of treatment. Values are expressed as mean ± S.D., % of body weight at sacrifice (n = 5); L, left sides; S, splenic lobes; aPopliteal lymph node; * p < 0.05 as compared with vehicle control. Observed animals/total observed animals (n = 5); aBilateral popliteal lymph node.
brain, and uterus.
Statistical analyses. Multiple comparison tests for different dose groups were conducted. Variance homogeneity was examined using the Levene test. If the Levene test indicated no significant deviations from variance homogeneity, the obtain data were analyzed by one way ANOVA test followed by Scheffe test to determine which pairs of group comparison were significantly different. In case of significant deviations from variance homogeneity were observed at Levene test, a non-parametric comparison test, the Mann-Whitney U-Wilcoxon Rank Sum W test was conducted to determine the specific pairs of Congestion 1 + PR extracts 500mg/kg Male 01 Congestion 1 + group comparison, which are significantly different. LD50 and 95% confidence limits were calculated by Probit method. Statistical analyses were conducted using SPSS for Windows (Release 14.0 K, SPSS Inc., USA) and a p-value of less than 0.05 was considered to be a significant difference. In addition, degree of clinical signs, gross and histopathological findings were subdivided into 3 degrees: 3+ Severe, 2+ moderate, 1 + slight. Clinical signs. In this study, no PR extracts-treatment related abnormal clinical signs were observed during observation periods regardless of male and female mice.
RESULTS

Mortalities
Changes in body weights and gains. No mean-
ingful changes on body weight and gains were detected in all dosing groups tested compared to that of vehicle control in all dose levels tested ( Fig. 1 and 2 
Necropsy findings.
No meaningful changes on the gross findings of 12 principle organs were observed in all dosing groups tested compared to that of vehicle control except for some accidental findings such as congestion spots of lung, atrophy of thymus, spleen atrophy or hypertrophy, hypertrophy of popliteal lymph node, edematous changes of uterus, and hypertrophy of popliteal lymph nodes. They were randomly detected throughout the whole experimental groups including each gender of vehicle controls, and most of these sporadic gross findings do not showed dosedependent frequencies encounted. Atypical whiteyellow focal foci in liver were restrictly detected in one mouse of PR extracts 500mg/kg treated male (Table 4) .
Histopathological findings. No meaningful changes
in the histopathological findings of 12 principle organs were observed in all dosing groups tested compared to that of vehicle control except for some sporadic acci- .
( ' ') ,
. . dental findings such as hypertrophy of lung alveolus wall as congestion (Fig, 3) , depletion of lymphoid cells in the cortex of thymus (Fig, 4) and white pulp of spleen (Fig, 5) , focal necrosis and inflammatory cell infiltration in liver (Fig, 6) , desquamation of the uterus mucosa (Fig, 7) , They were randomly detected throughout the whole experimental groups including each gender of vehicle controls, and most of these sporadic histopathological findings do not show dose-dependent frequencies encounted, In addition, somewhat increases in frequency of liver fatty changes were detected in PR extracts 2000 and 1000 mgtkg treated male and female groups (Fig, 8) ; only one mouse in male and female vehicle control showed slight (1+) hepatic fatty changes but four to two mice in PR extracts 2000 and 1000 mgt kg treated male and female groups showed slight (1+) hepatic fatty changes with one mice in PR extracts 500mgtkg treated groups (Table 5) ,
DISCUSSION
In the present study, we investigated the acute toxicity of single oral dose with PR extracts, lyophilized water extract of dried tuber of Pinellia temata to female and male mice as a part of the safety test. PR extracts were once orally administered to female and male ICR mice at dose levels of 2000, 1000, 500 and 0 mgtkg according to the recommendation of KFDA Guidelines Fig. 7 . Histopathological changes detected in the uterus. Note that desquamation of the uterus mucosa (DM) were detected as a process of estrus cycle. They were randomly detected throughout the whole female groups including vehicle control. All Hematoxylin & Eosin stain; Scale bars = 160 ~Lm. 2005) . The mortality and changes in body weight, clinical signs and gross observation were monitored during 14 days after treatment of PR extracts with organ weight and histopathology of 12 types of principle organs.
As the results, we could not find any mortality, clinical signs, changes in the body weight and gross findings and some sporadic gross findings. In addition, no meaningful changes in the organ weight and histopathology of 12 types of principle organs were detected in the present study except for dose-dependent increases of frequencies of hepatic fatty changes in PR extracts 2000 and 1000 mg/kg treated both male and female mice, and some sporadic accidental histopathological findings with dose-independent decreases of thymic absolute and relative weights in male 500 mg/kg treated mice, relative brain weights in female 500 mg/kg treated mice, respectively.
The body weight detected in this study was well corresponded to the body weight ranges of same aged normal mice as previously (Plata and Murphy, 1972; Yamaguchi et a/., 1983) in all tested groups including both male and female vehicle control, respectively. It means PR extracts did not induce any harmful changes on the body weights.
In KFDA Guidelines (2005 -60, 2005 and OEeD Guidelines (#423, 2001), the recommended highest dose of test materials were 2000 mg/kg or the maximum solubility, and they also recommended that in case of acute toxicity in mice, the dosage volume were below 20 ml/kg in case of clear soluble materials but 10 ml/kg in suspensions. In the present study, the highest dose of PR extracts was selected as 2000 mg/kg because PR extracts have been used as folk medicine #423, 2001) , and treated in a volume of 20 ml/kg using distilled water as vehicle because PR extracts were clearly dissolved upto 100mg/ml, at least in the present study.
Significant (p < 0.05) decreases of absolute and relative thymic weights in PR extracts 500 mg/kg male mice, and relative brain weights in PR extracts 500mgl kg male mice were considered as not PR extracts-treatment related changes because they were not showed dose-dependency with no changes on the histopathological profiles, and the other organ weights measured in this study well corresponded to the normal mice organ weight ranges as previously (Plata and Murphy, 1972; Yamaguchi et a/., 1983) .
The depletion of lymphoid cells in thymus detected in one animal of male vehicle control was considered as a result of physiological involution (Banks, 1986) , and splenic white pulp lymphoid cells depletion detected in one female vehicle control mouse is also considered as individual changes. Edematous changes in the uterus at gross findings and related desquamation of uterus mucosa at histopathological observation in the present study were also considered as a result of differences of physiological estrus cycles (Banks, 1986; Pineda, 1989) not PR extracts-dosing relative changes. They were also detected in vehicle control. The atypical yellow foci detected in one mouse of PR extract 500 mg/kg treated group revealed as slight fatty changes at histopathological observations.
The dose-dependent increases of frequencies of hepatic fatty changes detected in PR extracts 2000 and 1000 mg/kg treated both male and female mice, considered as direct evidences that PR extracts can be induced hepatotoxicity. The fatty changes in hepatocytes have been regarded as mild damages of liver (Maclachlan and Cullen, 1995) . However, in the previous PR extracts 4 weeks repeated oral dose toxicity test in rat (Lee et a/., 2003) , the possibilities of hepatotoxicity did not suggested. Therefore, it is considered that the toxicity of PR extracts have species-specific patterns.
Congestion spots of lung, atrophy of thymus, spleen atrophy or hypertrophy, hypertrophy of popliteal lymph node and hypertrophy of popliteal lymph nodes detected as gross findings, and hypertrophy of lung alveolus wall as congestion and focal necrosis and inflammatory cell infiltration in liver detected as histopathological findings were considered as accidental findings and they were not considered as PR extracts-treatment related abnormal gross or histopathological findings because they were restricted in some individual animals and most of them, also observed in male and female vehicle controls .. In addition, most of them were rarely observed in normal mice (Lee et a/., 2005 .
Although the Hodge and Sterner (1949) classify as non toxic materials those LD50 were 5000-15000 mg/kg and the materials those LD50 were 500-5000 mg/kg also classified as relatively low toxic (Class III) by US Environmental Protection Agency (OPPTS 870.100, 1998) , recently Notified Guidelines by KFDA 2005 ) and OECD Guidelines (#423, 2001) recommended that the highest oral dose of test materials was 2000 mg/kg. The LDse and ALD in mice after single oral dose of PR extracts were detected over 2000mg/kg in both male and female in the present study. However, more than 1000 mg/kg of PR extracts treatment could be induced slight hepatotoxicity in mice, the fatty changes.
